Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tousseyn

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Blood|September 6, 2013
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphomaMichela Boi, Andrea Rinaldi, Ivo Kwee, et al.
Cancers|April 23, 2022
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical ApproachFleur A de Groot, Ruben A L de Groen, Anke van den Berg, et al.
Haematologica|August 5, 2018
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Sofie Peirs, Julie Morscio, et al.
Plos Medicine|December 14, 2016
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution StudyRobert Kridel, Fong Chun Chan, Anja Mottok, et al.
Cell Reports. Medicine|December 10, 2024
Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disordersJiaying Toh, Andrea J Reitsma, Tetsuya Tajima, et al.
Blood Neoplasia|June 2, 2025
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in BelgiumPaul G Kemps, F J Sherida H Woei-A-Jin, Patrick Schöffski, et al.
Blood Advances|October 3, 2024
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosisPaul G Kemps, F J Sherida H Woei-A-Jin, Koen D Quint, et al.
The Journal of Allergy and Clinical Immunology|April 21, 2020
Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndromeRosita Rigoni, Elena Fontana, Kerry Dobbs, et al.
Cancer Cell|April 16, 2015
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphomaRamona Crescenzo, Francesco Abate, Elena Lasorsa, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in miceCarolina Vicente-Dueñas, Lorena Fontán, Ines Gonzalez-Herrero, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Blood|September 6, 2013
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphomaMichela Boi, Andrea Rinaldi, Ivo Kwee, et al.
Cancers|April 23, 2022
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical ApproachFleur A de Groot, Ruben A L de Groen, Anke van den Berg, et al.
Haematologica|August 5, 2018
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Sofie Peirs, Julie Morscio, et al.
Plos Medicine|December 14, 2016
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution StudyRobert Kridel, Fong Chun Chan, Anja Mottok, et al.
Cell Reports. Medicine|December 10, 2024
Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disordersJiaying Toh, Andrea J Reitsma, Tetsuya Tajima, et al.
Blood Neoplasia|June 2, 2025
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in BelgiumPaul G Kemps, F J Sherida H Woei-A-Jin, Patrick Schöffski, et al.
Blood Advances|October 3, 2024
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosisPaul G Kemps, F J Sherida H Woei-A-Jin, Koen D Quint, et al.
The Journal of Allergy and Clinical Immunology|April 21, 2020
Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndromeRosita Rigoni, Elena Fontana, Kerry Dobbs, et al.
Cancer Cell|April 16, 2015
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphomaRamona Crescenzo, Francesco Abate, Elena Lasorsa, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in miceCarolina Vicente-Dueñas, Lorena Fontán, Ines Gonzalez-Herrero, et al.
Pageof 18